- This event has passed.
Connected health — Is this our future?
Using online technology to manage health and wellness post-COVID (And save money with life-long benefits!)
You are invited to attend the next ATSE & UUSC luncheon series presentation on 30 March 2022, to hear of the remarkable developments in implanted and/or wearable sensors operating in a fully integrated digital ecosystem which will provide continuity of care from the hospital, to the community, to the home, saving lives at the same time saving money.
We live in a world where technology is increasingly assisting healthcare workers to remotely monitor and manage health. We can monitor our own wellness via fitness trackers, smart watches and mobile phone technology; the future of monitoring and managing health and wellness – Connected Health – lies in developing intelligent systems that address clinical and patient needs by connecting software, hardware, medical technologies and data analytics to provide unparalleled integration of health data to develop the best solution tailored for the individual person and do so in real time. It is critical that these Connected Health approaches align with existing clinical workflows.
Leading medical researchers and ATSE Fellows, Professor Laura Poole-Warren and Professor Nigel Lovell will be joined by Dr Sze-Yuan Ooi to present two remarkable developments in Connected Health. The recently established Tyree Institute of Health Engineering (IHealthE) at Prince of Wales Hospital and School of Biomedical Engineering (UNSW) aims to be a global leader in transforming health care practice and delivery by developing innovative, transformational, and cost-effective health technologies to meet patient and clinician needs.
World first developments by IHealthE, including a patient-centred, remote monitoring smartphone application system (TCC) already in trials links community-based patients with hospital specialists, enabling management of patients with coronary disease, heart failure and stroke in the community, with further development of TCC to manage chronic obstructive pulmonary disease, mental health, and gestational diabetes.